Armistice Capital’s Imunon IMNN Stock Holding History

Armistice Capital’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.02M	Buy	348,330 +81,444	+31%	+$268K	0.02%	164
2025 Q4	$1.02M	Buy	+266,886	New	+$1.14M	0.01%	175

Other funds holding IMNN

RCA

Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Armistice Capital's IMNN Position: Q1 2026 in Review

Armistice Capital increased its Imunon (IMNN) stake by 31% in Q1 2026, buying an estimated $268K and bringing the position to 348,330 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #164.

Armistice Capital first reported a position in IMNN in Q4 2025 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold IMNN as of Q1 2026.

Armistice Capital held 348,330 shares of Imunon worth $1.02M as of Q1 2026.
Armistice Capital bought 81,444 Imunon shares in Q1 2026, an estimated $268K.
Imunon made up 0.02% of Armistice Capital's portfolio in Q1 2026, its #164 holding.
Armistice Capital first reported a position in Imunon in Q4 2025 and has held it in 2 quarters since.
19 funds tracked by Wall St. Rank held Imunon as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.